McEwen Mining Inc. is constructing a ramp at its Stock Mine to enhance gold production, reduce costs, and improve operational efficiency. Meanwhile, ABVC BioPharma's affiliate OncoX BioPharma Inc. has acquired the Lycogen® platform, expected to generate revenue in oncology, dermatology, and nutraceutical sectors. ABVC's strategic product licensing model is successful, with a deal valued at up to $105 million, tapping into the growing oncology drug market and lycopene-based ingredients market.